Jiangxi Runquankang Biological Technology Co., Ltd.

Jiangxi runquankang biological technology Co., Ltd. is a professional pharmaceutical raw materials manufcaturer. The factory is located in the industrial park of guantian town, chongyi county, ganzhou city. The company has registered capital of 50 million yuan, covering an area of 8, 000 square meters, and has 99 employees. The company has a strong competitiveness in domestic and foreign markets with the production of pharmaceutical raw material chloramphenicol, DL chloramphenicol, heparin sodium and sweentener sodium saccharin. The company has established a perfect quality control system and has a trained QA, QC management team and advanced inspection facilities and testing methods. All the workshop design of the company has reached the national new GMP certification, and the core product production workshop is designed and constructed according to the FDA and EU CEP standard. The company insists on the innovation of science and technology as the driving force, the establishment of the advanced technology center of the infrastructure, built a relatively perfect technological innovation system. Through independent research and development, technical cooperation and the introduction of digestible absorption and other channels, continuously promote product technology upgrading. The company leads the product quality and the production technology is the leading domestic level, has the remarkable competitive advantage. The company set up product marketing center in nanchang, set up extensive marketing network, product sales throughout India, South Korea, the United States, Brazil, Spain and so on more than 30 countries and regions. Adhering to the "pioneering work, fraternity and win-win" spirit of enterprise, fully relying on jiangxi university of traditional Chinese medicine production, the integration of science and technology innovation platform, integration of modern logistics distribution operation platform, and international business integration platform, enhance the brand value of the enterprise, to become a high-tech, high-quality export-oriented biopharmaceutical companies.